Humana, Cohere Health To Expand Collaboration To Boost Physician, Member Experience

Today Cohere Health, an intelligent utilization management technology provider, said on Monday that Humana Inc. (HUM) will expand its use of Cohere's digital UM collaboration platform to enable prior authorization for cardiovascular and surgical services.

"In addition to digitizing prior authorization requests for these services, the technology automates clinical intelligence into the provider's workflow, enabling episode-based, longitudinal management of the patient's care journey to reduce care variation, drive higher quality care, and minimize administrative burden," the company said in a statement.

Both solutions will be deployed nationwide on January 1, 2023 for Humana Medicare Advantage members and Humana staff.

For surgical services, Humana staff will use the Cohere Unify platform to support patient access to care by facilitating the review and approval of surgical procedure prior authorization requests.

By ensuring requests are reviewed expeditiously, the platform helps providers and patients avoid the complications that can arise from delayed care.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Integrated energy company Chevron reported Friday that profit for the fourth quarter increased 25 percent from last year, reflecting 17 percent revenue growth amid higher realizations and higher margins on refined product sales. Adjusted earnings per share missed analysts' estimates, while quarterly revenues topped it. Reno, Nevada-based ZLINE Kitchen and Bath has expanded its recall of gas ranges citing serious risk of injury or death from carbon monoxide poisoning, the U.S. Consumer Product Safety Commission announced. The recall now includes about 30,000 units of ZLINE gas ranges, including about 28,000 units... The Food and Drug Administration's independent advisory committee unanimously recommended replacing the current original COVID vaccines used in the U.S. for primary shots with new bivalent omicron shots authorized as boosters, reports said. The committee also considered the proposal for annual COVID vaccination, however, didn't vote on it.
Follow RTT